Arcutis Biotherapeutics, Inc.
ARQT
Helyezés a részvények között
#4008
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Részvényárfolyam
$32.29
Utolsó szinkronizálás: 2026-10-19
Piaci kapitalizáció
$4.06B
Változás (1 nap)
12.02%
Változás (1 év)
54.62%
Ország
US
Kereskedés Arcutis Biotherapeutics, Inc. (ARQT)
Kategória
Healthcare
Arcutis Biotherapeutics, Inc. (ARQT) osztalékhozamának története
Arcutis Biotherapeutics, Inc. (tőzsdei szimbólum: ARQT) osztalékhozama (TTM) 2023-12-31 állapot szerint: 0.00%
Átlagos osztalékhozam az elmúlt 5 évben: 0.00%
Átlagos osztalékhozam az elmúlt 5 évben: 0.00%
Arcutis Biotherapeutics, Inc. (ARQT) osztalékhozamainak története 2017 és 2026 között
Éves záró osztalékhozam (TTM)
| Év | Osztalékhozam | Változtassa meg |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
Hasonló cégek vagy versenytársak osztalékhozamai (TTM)
| Vállalat | Osztalékhozam | Ország |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
